| Autor: |
Nguyen, Hoang-Tuan, Rissanen, Siiri-Liisa, Peltokangas, Mimosa, Laakkonen, Tino, Kettunen, Jere, Barthod, Lara, Sivakumar, Ragul, Palojärvi, Anniina, Junttila, Pauliina, Talvitie, Jussi, Bassis, Michele, Nickels, Sarah L., Kalvala, Sara, Ilina, Polina, Tammela, Päivi, Lehtonen, Sarka, Schwamborn, Jens C., Mosser, Sebastien, Singh, Prateek |
| Předmět: |
|
| Zdroj: |
Tissue Barriers; 2024, Vol. 12 Issue 4, p1-20, 20p |
| Abstrakt: |
The development of new therapies is hampered by the lack of predictive, and patient-relevant in vitro models. Organ-on-chip (OOC) technologies can potentially recreate physiological features and hold great promise for tissue and disease modeling. However, the non-standardized design of these chips and perfusion control systems has been a barrier to quantitative high-throughput screening (HTS). Here we present a scalable OOC microfluidic platform for applied kinetic in vitro assays (AKITA) that is applicable for high, medium, and low throughput. Its standard 96-well plate and 384-well plate layouts ensure compatibility with existing laboratory workflows and high-throughput data collection and analysis tools. The AKITA plate is optimized for the modeling of vascularized biological barriers, primarily the blood-brain barrier, skin, and lung, with precise flow control on a custom rocker. The integration of trans-epithelial electrical resistance (TEER) sensors allows rapid and repeated monitoring of barrier integrity over long time periods. Together with automated liquid handling and compound permeability testing analyses, we demonstrate the flexibility of the AKITA platform for establishing human-relevant models for preclinical drug and precision medicine's efficacy, toxicity, and permeability under near-physiological conditions. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
